Ardelyx Says China Approves New Drug Application for Hyperphosphatemia Treatment Tenapanor; Shares Up Pre-Bell
In This Article:
Ardelyx (ARDX) said Wednesday that a new drug application for tenapanor for the treatment of hyperph
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Terms and Privacy Policy